These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2676935)

  • 41. Clinical isolates of Escherichia coli producing TRI beta-lactamases: novel TEM-enzymes conferring resistance to beta-lactamase inhibitors.
    Vedel G; Belaaouaj A; Gilly L; Labia R; Philippon A; Névot P; Paul G
    J Antimicrob Chemother; 1992 Oct; 30(4):449-62. PubMed ID: 1490918
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of TEM-26 beta-lactamase responsible for a major outbreak of ceftazidime-resistant Klebsiella pneumoniae.
    Urban C; Meyer KS; Mariano N; Rahal JJ; Flamm R; Rasmussen BA; Bush K
    Antimicrob Agents Chemother; 1994 Feb; 38(2):392-5. PubMed ID: 8192474
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation of beta-lactamase stability and antibacterial activity of beta-lactams in beta-lactamase-producing bacteria and respective transconjugants.
    Esposito S; Galante D; Barba D; Pennucci C; Limauro D
    Drugs Exp Clin Res; 1986; 12(4):329-33. PubMed ID: 3522155
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Typing of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella spp. strains and analysis of plasmid profiles].
    Oksüz L; Gürler N
    Mikrobiyol Bul; 2009 Apr; 43(2):183-94. PubMed ID: 19621602
    [TBL] [Abstract][Full Text] [Related]  

  • 45. beta-Lactamase Id of ceftazidime-resistant Pseudomonas aeruginosa strains.
    Michel-Briand Y; Nicolas T; Godard C; Plesiat P
    Microbiologica; 1992 Jan; 15(1):65-9. PubMed ID: 1556960
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of beta-lactamases responsible for resistance to extended-spectrum cephalosporins in Escherichia coli and Salmonella enterica strains from food-producing animals in the United Kingdom.
    Liebana E; Gibbs M; Clouting C; Barker L; Clifton-Hadley FA; Pleydell E; Abdalhamid B; Hanson ND; Martin L; Poppe C; Davies RH
    Microb Drug Resist; 2004; 10(1):1-9. PubMed ID: 15140388
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Klebsiella oxytoca: resistance to aztreonam by overproduction of the chromosomally encoded beta-lactamase.
    Fournier B; Arlet G; Lagrange PH; Philippon A
    FEMS Microbiol Lett; 1994 Feb; 116(1):31-6. PubMed ID: 8132152
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Substitution of serine for arginine in position 162 of TEM-type beta-lactamases extends the substrate profile of mutant enzymes, TEM-7 and TEM-101, to ceftazidime and aztreonam.
    Collatz E; Tran Van Nhieu G; Billot-Klein D; Williamson R; Gutmann L
    Gene; 1989 May; 78(2):349-54. PubMed ID: 2506109
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne
    Shields RK; Chen L; Cheng S; Chavda KD; Press EG; Snyder A; Pandey R; Doi Y; Kreiswirth BN; Nguyen MH; Clancy CJ
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031201
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of multiresistant ceftazidime-susceptible Klebsiella pneumoniae isolates lacking TEM-26 after class restriction of cephalosporins.
    Urban C; Mariano N; Rahman N; Queenan AM; Montenegro D; Bush K; Rahal JJ
    Microb Drug Resist; 2000; 6(4):297-303. PubMed ID: 11272258
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TEM-28 from an Escherichia coli clinical isolate is a member of the His-164 family of TEM-1 extended-spectrum beta-lactamases.
    Bradford PA; Jacobus NV; Bhachech N; Bush K
    Antimicrob Agents Chemother; 1996 Jan; 40(1):260-2. PubMed ID: 8787920
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TEM-89 beta-lactamase produced by a Proteus mirabilis clinical isolate: new complex mutant (CMT 3) with mutations in both TEM-59 (IRT-17) and TEM-3.
    Neuwirth C; Madec S; Siebor E; Pechinot A; Duez JM; Pruneaux M; Fouchereau-Peron M; Kazmierczak A; Labia R
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3591-4. PubMed ID: 11709345
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dissemination of transferable CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli in Korea.
    Jeong SH; Bae IK; Kwon SB; Lee JH; Song JS; Jung HI; Sung KH; Jang SJ; Lee SH
    J Appl Microbiol; 2005; 98(4):921-7. PubMed ID: 15752339
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in an urban hospital in Dhaka, Bangladesh.
    Rahman MM; Haq JA; Hossain MA; Sultana R; Islam F; Islam AH
    Int J Antimicrob Agents; 2004 Nov; 24(5):508-10. PubMed ID: 15519486
    [TBL] [Abstract][Full Text] [Related]  

  • 55. OHIO-1 beta-lactamase mutants: Asp179Gly mutation confers resistance to ceftazidime.
    Bonomo RA; Rudin SD; Shlaes DM
    FEMS Microbiol Lett; 1997 Jul; 152(2):275-8. PubMed ID: 9231421
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibitor-sensitive AmpC beta-lactamase variant produced by an Escherichia coli clinical isolate resistant to oxyiminocephalosporins and cephamycins.
    Doi Y; Wachino J; Ishiguro M; Kurokawa H; Yamane K; Shibata N; Shibayama K; Yokoyama K; Kato H; Yagi T; Arakawa Y
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2652-8. PubMed ID: 15215122
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class a beta-lactamase, GES-3, in a neonatal intensive care unit in Japan.
    Wachino J; Doi Y; Yamane K; Shibata N; Yagi T; Kubota T; Ito H; Arakawa Y
    Antimicrob Agents Chemother; 2004 Jun; 48(6):1960-7. PubMed ID: 15155185
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
    Zarakolu P; Metan G; Hasçelik G; Akova M
    Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Detection of CTX-M-15 type extended spectrum beta-lactamase in an Escherichia coli strain isolated from the urine sample of a hospitalized patient].
    Aktaş Z; Gönüllü N; Schneider I; Bal C; Bauernfeind A
    Mikrobiyol Bul; 2005 Oct; 39(4):421-9. PubMed ID: 16544543
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activity of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV β-lactamases with single amino acid substitutions in the Ω-loop.
    Winkler ML; Papp-Wallace KM; Bonomo RA
    J Antimicrob Chemother; 2015 Aug; 70(8):2279-86. PubMed ID: 25957381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.